Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
700.33
+4.31 (0.62%)
Feb 21, 2025, 4:00 PM EST - Market closed
Regeneron Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 74,953 | 76,639 | 93,403 | 77,057 | 66,029 | 50,990 | Upgrade
|
| Market Cap Growth | -17.95% | -17.95% | 21.21% | 16.70% | 29.49% | 24.22% | Upgrade
|
| Enterprise Value | 59,979 | 61,056 | 80,414 | 66,767 | 57,309 | 47,783 | Upgrade
|
| Last Close Price | 700.33 | 711.42 | 877.16 | 720.56 | 630.71 | 482.49 | Upgrade
|
| PE Ratio | 18.27 | 17.37 | 23.62 | 17.76 | 8.18 | 14.51 | Upgrade
|
| Forward PE | 16.25 | 15.19 | 19.36 | 17.29 | 11.00 | 14.28 | Upgrade
|
| PS Ratio | 5.32 | 5.40 | 7.12 | 6.33 | 4.11 | 6.00 | Upgrade
|
| PB Ratio | 2.56 | 2.61 | 3.60 | 3.40 | 3.52 | 4.62 | Upgrade
|
| P/TBV Ratio | 2.72 | 2.72 | 3.75 | 3.54 | 3.52 | 4.62 | Upgrade
|
| P/FCF Ratio | 20.45 | 20.91 | 24.10 | 17.41 | 10.11 | 25.45 | Upgrade
|
| P/OCF Ratio | 16.96 | 17.34 | 20.33 | 15.37 | 9.32 | 19.48 | Upgrade
|
| PEG Ratio | 1.11 | 0.95 | 4.75 | - | - | 1.55 | Upgrade
|
| EV/Sales Ratio | 4.22 | 4.30 | 6.13 | 5.48 | 3.57 | 5.62 | Upgrade
|
| EV/EBITDA Ratio | 12.96 | 13.19 | 17.28 | 12.51 | 6.17 | 12.25 | Upgrade
|
| EV/EBIT Ratio | 14.47 | 14.73 | 19.00 | 13.37 | 6.37 | 13.04 | Upgrade
|
| EV/FCF Ratio | 16.37 | 16.66 | 20.75 | 15.09 | 8.78 | 23.85 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.11 | 0.12 | 0.14 | 0.24 | Upgrade
|
| Debt / EBITDA Ratio | 0.63 | 0.63 | 0.60 | 0.52 | 0.29 | 0.69 | Upgrade
|
| Debt / FCF Ratio | 0.80 | 0.80 | 0.72 | 0.63 | 0.41 | 1.35 | Upgrade
|
| Asset Turnover | 0.40 | 0.40 | 0.42 | 0.45 | 0.75 | 0.53 | Upgrade
|
| Inventory Turnover | 2.51 | 2.51 | 2.51 | 2.37 | 2.74 | 2.26 | Upgrade
|
| Quick Ratio | 3.86 | 3.86 | 4.82 | 4.16 | 2.98 | 2.86 | Upgrade
|
| Current Ratio | 4.73 | 4.73 | 5.69 | 5.06 | 3.56 | 3.63 | Upgrade
|
| Return on Equity (ROE) | 15.95% | 15.95% | 16.26% | 20.94% | 54.21% | 31.77% | Upgrade
|
| Return on Assets (ROA) | 7.31% | 7.31% | 8.49% | 11.42% | 26.39% | 14.33% | Upgrade
|
| Return on Capital (ROIC) | 8.49% | 8.49% | 9.76% | 13.31% | 31.95% | 17.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.26% | 12.26% | 14.27% | 19.15% | 41.83% | 25.33% | Upgrade
|
| Earnings Yield | 5.89% | 5.76% | 4.23% | 5.63% | 12.23% | 6.89% | Upgrade
|
| FCF Yield | 4.89% | 4.78% | 4.15% | 5.74% | 9.89% | 3.93% | Upgrade
|
| Buyback Yield / Dilution | -1.23% | -1.23% | -0.18% | -1.16% | 2.52% | -0.44% | Upgrade
|
| Total Shareholder Return | -1.11% | -1.23% | -0.18% | -1.16% | 2.52% | -0.44% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.